Tampa, Florida 2021-10-27 13:43:11 –
On Wednesday, the White House’s COVID-19-capable team will hold a virtual briefing as the Food and Drug Administration is considering a Pfizer vaccine for children ages 5-11.
on TuesdayThe FDA’s Vaccine and Related Biopharmaceutical Advisory Board unanimously recommended that the Pfizer vaccine be available to children up to the age of 5 on an emergency use basis.
Overall, the FDA still needs to make recommendations before the Centers for Disease Control and Prevention can address the issue.
The CDC’s Immunization Implementation Advisory Board has already set up a meeting on November 2nd and 3rd, and the panel may vote on whether to issue its own recommendations on Pfizer vaccines for children.
Once ACIP issues a recommendation, CDC Director Dr. Rochelle Walensky must issue a final approval.
Health professionals such as White House medical adviser Dr. Anthony Fauci believe that the Pfizer COVID-19 vaccine will be available to children by early November.
There is also a White House briefing Less than a week After the CDC approves new guidance for vaccine booster shots.
People over the age of 65 who have been vaccinated with the Moderna vaccine should take booster shots if they are in a fundamental condition of being vulnerable to COVID-19 or living or working in a location at risk of infection. You can look for it. In addition, individuals who have received a single Johnson & Johnson vaccination can seek booster immunization two months after the initial dose.
The CDC has also issued final approval for guidance that will allow Americans to receive booster shots of any brand, regardless of the initial vaccine received.
The White House COVID-19 team will meet at 2:30 pm Eastern Standard Time.
White House holds COVID briefing as regulators weigh vaccines for kids Source link White House holds COVID briefing as regulators weigh vaccines for kids